Senior Therapy Access Manager

and within the industry’s legal and regulatory framework. Additionally, the Senior TAM will lead process improvement projects and assist with training and onboarding of new TAMs. Senior TAMs may also serve in team lead roles for internal and/or external partners as appropriate. Serves as a mentor for TAMs. May assist with data analytics and reporting to support team initiatives., * Execute institutional and field access strategy for their responsible geography

• Identify and educate key clinic/institution stakeholders on reimbursement dynamics, patient support services, distribution model, and payer requirements to gain access to the product

• Partner with the Sales Account Managers, Clinical Coordinators, and Patient Support Services Hub to ensure HCPs can navigate patient access needs; lead proactive touchpoints with internal matrix partners to keep all parties informed for relevant account planning purposes

• Conduct/monitor complex Benefits Investigations, provide results to clinics, and educate on Prior Authorization processes. Monitor PA process and provide additional education as needed.

• Act as a liaison between the patient support services hub and the HCP clinic to educate providers on patient support programs. This will include educating the staff at the institution or clinic that is responsible for managing all aspects of patient access to therapy utilizing BioMarin resources including, but not limited to coverage authorization guides, Co-Pay assistance programs and other hub and patient support services
• Provide live one-on-one educational support to HCP and/or office staff and address questions about coverage requirements, including education on the payers’ coverage authorization requirements and process
• May reactively interact with patients for complex access issues as needed while maintaining compliance standards at all times
• Champion compliance and ethical standards, mentoring junior team members on best practices within a regulated environment
• Analyze payer trends and institutional feedback to inform strategic adjustments and support escalation pathways for challenging cases
• Educate HCPs, office staff, and institutions on payer issues, policies/guidelines, trends, common reasons for PA delays, denials, and appeal processes
• Review escalated individual patient cases to identify and address any coverage barriers; proactively scan payer policies tailored to each clinic’s needs and provide regular updates based on market dynamics
• Travel up to 50% to support above responsibilities, as needed; represent team at national meetings as appropriate, Note: This description is not intended to be all-inclusive, or a limitation of the duties of the position. It is intended to describe the general nature of the job that may include other duties as assumed or assigned.

The Senior Therapy Access Manager will be responsible for the execution of the therapy access strategy for the assigned portfolio of commercialized therapies. The Senior TAM will support patient access and site of care onboarding by partnering with all relevant internal teams including Patient Access Services, National Accounts Sales, Clinical Coordinators, Marketing, Trade and Compliance and providing product access education to Institutional Administrators, HCPs and their office staff. This role requires strategic, tactical, operational, organizational, problem solving, communications, and project management skills. Strong results orientation and a sense of urgency to get things done are critical. This professional is an architect of creative solutions that embraces innovative approaches and is comfortable in an entrepreneurial and growing commercial organization and committed to ethical behavior in every aspect of their duties and in compliance with company policies, * 7+ years of Pharmaceutical or Healthcare industries, preferably including 5+ years in access/reimbursement

• Bachelor’s degree required
• Proven track record of supporting HCPs and office staff in seeking access/reimbursement that required significant payer and reimbursement support
• Experience with both ‘buy and bill’ and Specialty Pharmacy distribution pathways for specialty oral and injectable medications
• Strong knowledge of the payer environment, including but not limited to: government and commercial payers, assignment of benefits, letter of agreements, accumulators, maximizers, manufacturer patient support programs
• Ability to professionally interact with customers - HCPs, office staff, institutions
• Excellent communication skills; strategizes proactive solutions for keeping stakeholders informed
• Solid knowledge of patient support programs including HUB programs, co-pay assistance programs, and nurse educator support
• Track record of effective collaboration in a highly matrixed environment
• Strong knowledge and understanding of Compliance with HIPAA regulations, OIG guidance, Advertising and Promotion requirements, the Anti-Kickback Statute, and applicable policies, best practices, and guidelines
• Strong planning and organization skills including OFFICE suite of productivity tools
• Rare Disease, Specialty, and Launch experience

PREFERRED EXPERIENCE

• Experience working within Salesforce.com
• Experience with REMS product(s)
• Experience with limited distribution product(s)

MINIMUM SKILLS, KNOWLEDGE, AND ABILITY REQUIREMENTS:

• Strong analytical skills.
• Strong organizational skills; attention to detail.
• Ability to travel overnight
• Ability to schedule individual work-related travel (air, hotel, rental car as needed).
• Ability to utilize own car for travel.
• Technical knowledge of healthcare from a patient and provider perspective (miscellaneous codes, billing codes, appeals process)

Must be willing to travel up to 50% of the time. Territory includes entire US and Puerto Rico.

Bilingual highly desirable. Nursing experience a plus.

For more than two decades, going our own way has led to countless breakthroughs, bettering the lives of those suffering from rare genetic disease. In 1997 we were founded to make a big difference in small patient populations. Now we seek to make an even greater impact by applying the same science-driven, patient-forward approach that propelled our last 25 years of drug development to larger genetic disorders, as well as genetic subsets of more common conditions. Through our unparalleled expertise in genetics and molecular biology, we will continue to develop targeted therapies that address the root cause of the conditions we seek to treat. Applying our knowledge to make a transformative impact is not just a calling, but an obligation to those who will benefit most. The end goal has always been better lives and now we can reach more.

And the more people we reach, the more our impact can grow. We transform lives through genetic discovery.

Our Culture

Our desire to make a positive impact on our patients extends to our employees and BioMarin is committed to fostering an inclusive environment where every person feels seen, valued, and heard - so employees can thrive in all areas of their lives, in and outside of work. We seek to provide an open, flexible, and friendly work environment to empower people and to provide them with the ability to develop their long-term careers. Ultimately, we want to be an organization where people enjoy coming to work and take pride in our efforts to help patients. BioMarin’s Commercial organization supports our global sales and marketing efforts around the world. Our global sales force continues to solidify the company’s commercial presence in the United States and Europe and is rapidly growing in other regions, such as Latin America, the Middle East and Asia-Pacific. Come join our team and make a meaningful impact on patients’ lives., BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions.

Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered a portfolio of therapies since our founding in 1997. Our revolutionary treatments for conditions like achondroplasia (the most common form of dwarfism), PKU (phenylketonuria), CLN2, a form of Batten disease, and a number of forms of MPS (mucopolysaccharidosis) offer new possibilities for patients and families who previously had few, if any, available options. More recently, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease, expanding our ability to reach more people living with rare genetic conditions.

Our success comes from our unwavering commitment to excellence, our deep understanding of patient needs, our scientific expertise, and our world-class manufacturing capabilities. At the heart of BioMarin is a dedicated team of the brightest minds in the industry working together to deliver innovative therapies to patients and families around the world.